HDAC INHIBITOR-TARGETED THERAPY WITH NANOMEDICINE INCREASES THE EFFICACY OF PACLITAXEL IN TRIPLE NEGATIVE BREAST CANCER
Master's
Saved in:
Main Author: | LIM CHEN SIEW |
---|---|
Other Authors: | CHEMICAL & BIOMOLECULAR ENGINEERING |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/79259 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
IDENTIFICATION OF NOVEL ONCOGENIC PATHWAYS IN A PACLITAXEL-RESISTANT MODEL OF TRIPLE NEGATIVE BREAST CANCER
by: VERA KATHERINA KOHLBAUER
Published: (2016) -
EPIGENETIC REGULATION OF CELL STATE TRANSITIONS IN TRIPLE NEGATIVE BREAST CANCER
by: TOH LI PING
Published: (2021) -
EPIGENETIC TARGETED DRUG DISCOVERY: INHIBITORS OF METHYLTRANSFERASE G9A AND DUAL INHIBITORS OF G9A and HDAC
by: UTTARA SOUMYANARAYANAN
Published: (2018) -
Poly(d,l-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy
by: Dong, Y., et al.
Published: (2014) -
Trastuzumab-decorated nanoparticles of biodegradable polymers for targeted small molecule chemotherapy
by: SUN BINGFENG
Published: (2010)